EUVIMEDEUVIMED entdecken
Crossref

Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism

Xiaoqiang Wu, Xuan Wu, Zhiwei Wang, Xiangyong Tian, Chan Zhang, Guanghui Cao, Yue Gu, Tianzhong Yan

Drug Delivery and Translational Research · 2025-03 · 15 (3) · 925-938

DOI: 10.1007/s13346-024-01645-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 25.06.2024. Verfasst von Xiaoqiang Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital, Zhengzhou University People'…. Hauptthemen laut MEDLINE: MicroRNAs, Reperfusion Injury, Mesenchymal Stem Cells, Kidney Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Key Scientific Research Projects in Universities of Henan Province, Henan Province Medical Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal ischemia-reperfusion injury (IRI) frequently occurs following kidney transplantation, and exosomes derived from umbilical cord mesenchymal stem cells (WJ-MSC-Exos) have shown promise in treating IRI in transplanted kidneys. Our study delved into the potential mechanism of WJ-MSC-Exos in ameliorating IRI in transplanted kidneys, revealing that miR-19b is abundantly present in WJ-MSC-Exos. Both in vivo and in vitro experiments demonstrated that the absence of miR-19b abolished the protective effects of WJ-MSC-Exos against renal IRI. Mechanistically, miR-19b suppressed glycogen synthase kinase-3β (GSK3β) expression, thereby stabilizing PDXK protein through direct binding. Treatment with WJ-MSC-Exos led to reduced PDXK levels and enhanced pyridoxine accumulation, ultimately mitigating IRI in transplanted kidneys and I/R-induced HK2 cell apoptosis. These findings elucidate the underlying mechanism of WJ-MSC-Exos in alleviating IRI in transplanted kidneys, unveiling novel therapeutic targets for post-kidney transplantation IRI and providing a solid theoretical foundation for the clinical application of WJ-MSC-Exos in IRI treatment post-transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsReperfusion InjuryMesenchymal Stem CellsKidney TransplantationAnimalsHumansExosomesWharton JellyMaleMiceKidneyApoptosisCell LineMesenchymal Stem Cell TransplantationMice, Inbred C57BLGlycogen Synthase Kinase 3 betaUmbilical Cord

Stichwörter der Autor:innen

Cellular metabolismExosomeRenal ischemia/ReperfusionWJ-MSCsmiR-19b

Substanzen

MicroRNAsMIRN19A microRNA, humanGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Department of Urology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China.
  • Department of Nephrology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China.
  • Department of Urology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, China. ytz460@hotmail…

Förderung

  • Key Scientific Research Projects in Universities of Henan Province
  • Henan Province Medical Science and Technology Research Project

Zitieren

APA

Wu, X., Wu, X., Wang, Z., Tian, X., Zhang, C., Cao, G., Gu, Y., & Yan, T. (2025). Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism. Drug Delivery and Translational Research, 15(3), 925-938. https://doi.org/10.1007/s13346-024-01645-3

Vancouver

Wu X, Wu X, Wang Z, Tian X, Zhang C, Cao G, et al. Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism. Drug Delivery and Translational Research. 2025;15(3):925-938. doi:10.1007/s13346-024-01645-3

BibTeX
@article{Wu2025,
  author = {Wu, Xiaoqiang and Wu, Xuan and Wang, Zhiwei and Tian, Xiangyong and Zhang, Chan and Cao, Guanghui and Gu, Yue and Yan, Tianzhong},
  title = {Delivery of exogenous miR-19b by Wharton’s Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {925--938},
  doi = {10.1007/s13346-024-01645-3}
}
Kostenlos starten →